ACTISOUFRE clinical trials

A prospective, controlled, randomized, double blind, 2-arms, parallel-group, multicentre, phase 3 study to investigate effectiveness of Actisoufre nasal spray in a pressurized container compared to placebo in female and male adult and paediatric population over 6 years old with acute rhinitis, rhinopharyngitis and rhinosinusitis not requiring antibiotic therapy.

This study is testing a nasal spray called Actisoufre to see if it helps adults and children (over 6) with common cold symptoms like a blocked or runny nose, sneezing, and thick mucus. It compares the spray to a placebo (a dummy spray).